UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

AB1020 Evaluation of the Disease Course of Italian Children with Juvenile Idiopathic Arthritis Treated with Etanercept: Preliminary Results in 1019 Patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1239-1240

2015

Link zum Volltext

Verfügbarkeit prüfen

SAT0447 Preliminary Definition of Cutoffs for High Disease Activity Based on Original and Simplified Jadas in Juvenile Idiopathic Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A733-A733

2013

Link zum Volltext

Verfügbarkeit prüfen

Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2011-01, Vol.63 (1), p.267-275

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis

Clinical and experimental rheumatology, 2021-03, Vol.39 (2), p.426

2021

Link zum Volltext

Verfügbarkeit prüfen

Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis

Clinical and experimental rheumatology, 2013-07, Vol.31 (4 Suppl 78), p.S98

2013

Link zum Volltext

Verfügbarkeit prüfen

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)

Pediatric rheumatology online journal, 2008-09, Vol.6 (S1), p.P77-P77, Article P77

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)

Pediatric rheumatology online journal, 2008-09, Vol.6 (S1), p.P114-P114, Article P114

2008

Link zum Volltext

Verfügbarkeit prüfen

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?

Pediatric rheumatology online journal, 2008-09, Vol.6 (S1), p.P103-P103, Article P103

2008

Link zum Volltext

Verfügbarkeit prüfen

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs

Pediatric rheumatology online journal, 2013-12, Vol.11 (S2), p.P145-P145, Article P145

2013

Link zum Volltext

Verfügbarkeit prüfen

PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients

Pediatric rheumatology online journal, 2013-12, Vol.11 (S2), p.P110-P110, Article P110

2013

Link zum Volltext

Verfügbarkeit prüfen

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

Pediatric rheumatology online journal, 2013-12, Vol.11 (S2), p.P155-P155, Article P155

2013

Link zum Volltext

Verfügbarkeit prüfen

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2014-09, Vol.12 (S1), p.P1-P1, Article P1

2014

Link zum Volltext

Verfügbarkeit prüfen

Chapter 7 - Juvenile Idiopathic Arthritis

The Heart in Rheumatic, Autoimmune and Inflammatory Diseases, 2017, p.167-187

2017

Link zum Volltext

Verfügbarkeit prüfen

Rotavirus and the web: analysis of online conversations in Italy during 2020

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2002087-2002087

2022

Link zum Volltext

Verfügbarkeit prüfen

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial

The Lancet (British edition), 2017-03, Vol.389 (10072), p.909-916

2017

Link zum Volltext

Verfügbarkeit prüfen

Parent and child acceptable symptom state in juvenile idiopathic arthritis

Journal of rheumatology, 2012-04, Vol.39 (4), p.856

2012

Link zum Volltext

Verfügbarkeit prüfen

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1380-1383

2014

Link zum Volltext

Verfügbarkeit prüfen

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2019-07, Vol.17 (1), p.50-50, Article 50

2019

Link zum Volltext

Verfügbarkeit prüfen

A30: Assessment of Construct and Discriminative Validity of the 3‐Variable JADAS in Relation of Parent‐Reported Outcomes

Arthritis & rheumatology (Hoboken, N.J.), 2014-03, Vol.66 (S3), p.S46-S46

2014

Link zum Volltext

Verfügbarkeit prüfen

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

Pediatric rheumatology online journal, 2016-12, Vol.14 (1), p.68, Article 68

2016

Link zum Volltext

Verfügbarkeit prüfen

Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis?

Pediatric rheumatology online journal, 2014-09, Vol.12 (S1), p.P174-P174, Article P174

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients

Pediatric rheumatology online journal, 2014-09, Vol.12 (S1), p.P130-P130, Article P130

2014

Link zum Volltext

Verfügbarkeit prüfen

WHICH AREAS IN THE WRISTS AND HANDS SHOULD BE INCLUDED IN A RADIOGRAPHIC SCORING SYSTEM FOR JUVENILE IDIOPATHIC ARTHRITIS?

Turkish journal of pediatrics, 2008-01, Vol.50, p.86

2008

Link zum Volltext

Verfügbarkeit prüfen

EXPERIENCE WITH THE USE OF TUMOR NECROSIS FACTOR ANTAGONISTS IN CHILDREN WITH TAKAYASU ARTERITIS

Turkish journal of pediatrics, 2008-01, Vol.50, p.13

2008

Link zum Volltext

Verfügbarkeit prüfen

EXPERIENCE WITH THE USE OF TUMOR NECROSIS FACTOR ANTAGONISTS IN CHILDREN WITH TAKAYASU ARTERITIS

Turkish journal of pediatrics, 2008-01, Vol.50, p.168

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)
Buchkapitel
(2)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(9)
Life Sciences & Biomedicine
(9)
Poster Presentation
(9)
Science & Technology
(9)
Rheumatology
(8)
Child
(7)
Treatment Outcome
(6)
Arthritis
(5)
Arthritis, Juvenile - Diagnosis
(5)
Juvenile Idiopathic Arthritis
(5)
Arthritis, Juvenile - Drug Therapy
(4)
Child, Preschool
(4)
Female
(4)
Male
(4)
Methotrexate
(3)
Patients
(3)
Pediatric Rheumatology
(3)
Retrospective Studies
(3)
Adolescent
(2)
Antirheumatic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AB1020 Evaluation of the Disease Course of Italian Children with Juvenile Idiopathic Arthritis Treated with Etanercept: Preliminary Results in 1019 Patients

SAT0447 Preliminary Definition of Cutoffs for High Disease Activity Based on Original and Simplified Jadas in Juvenile Idiopathic Arthritis

Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis

Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis

Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs

PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis

Chapter 7 - Juvenile Idiopathic Arthritis

Rotavirus and the web: analysis of online conversations in Italy during 2020

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial

Parent and child acceptable symptom state in juvenile idiopathic arthritis

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

A30: Assessment of Construct and Discriminative Validity of the 3‐Variable JADAS in Relation of Parent‐Reported Outcomes

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis?

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients

WHICH AREAS IN THE WRISTS AND HANDS SHOULD BE INCLUDED IN A RADIOGRAPHIC SCORING SYSTEM FOR JUVENILE IDIOPATHIC ARTHRITIS?

EXPERIENCE WITH THE USE OF TUMOR NECROSIS FACTOR ANTAGONISTS IN CHILDREN WITH TAKAYASU ARTERITIS

EXPERIENCE WITH THE USE OF TUMOR NECROSIS FACTOR ANTAGONISTS IN CHILDREN WITH TAKAYASU ARTERITIS

Suchergebnisse filtern